JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5601
Capricor Therapeutics
CAPR
$520M
| $51.6K | ﹤0.01% |
10,818
-80,265
| -88% | -$448K |
2024 Q1
1 quarter
|
|
5602
Harvard Bioscience
HBIO
$37M
| $51.6K | ﹤0.01% |
1,810
+139
| +8% | +$4.88K |
2019 Q4
18 quarters
|
|
5603
PUT
Shift4
FOUR
$2.81B
| $51.3K | ﹤0.01% |
700
-13,600
| -95% | -$901K |
2023 Q3
3 quarters
|
|
5604
BlackSky Technology
BKSY
$866M
| $51.3K | ﹤0.01% |
5,998
-217
| -3% | -$2.04K |
2023 Q2
4 quarters
|
|
5605
Century Therapeutics
IPSC
$292M
| $51.1K | ﹤0.01% |
20,057
-5,623
| -22% | -$17.8K |
2021 Q3
11 quarters
|
|
5606
State Street US Sector Rotation ETF
XLSR
$1.07B
| $50.9K | ﹤0.01% |
+1,000
| New | +$49.3K |
2024 Q2
0 quarters
|
|
5607
Kaltura
KLTR
$195M
| $50.7K | ﹤0.01% |
42,266
-113,472
| -73% | -$137K |
2022 Q4
6 quarters
|
|
|
NREF
5608
NexPoint Real Estate Finance
NREF
$297M
| $50.7K | ﹤0.01% |
3,696
-14,083
| -79% | -$190K |
2021 Q1
13 quarters
|
|
|
RAPT
5609
DELISTED
RAPT Therapeutics
RAPT
| $50.5K | ﹤0.01% |
2,072
-359
| -15% | -$16.6K |
2019 Q4
18 quarters
|
|
5610
Sanara MedTech
SMTI
$320M
| $50.4K | ﹤0.01% |
1,786
+180
| +11% | +$5.65K |
2023 Q1
5 quarters
|
|
5611
PUT
Allegiant Air
ALGT
$2.06B
| $50.2K | ﹤0.01% |
+1,000
| New | +$56K |
2024 Q2
0 quarters
|
|
5612
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$602M
| $50.2K | ﹤0.01% |
407
-1
| -0.2% | -$121 |
2022 Q4
6 quarters
|
|
|
KWY
5613
Kingsway Corp
KWY
$270M
| $50.2K | ﹤0.01% |
6,094
-10,962
| -64% | -$90.9K |
2023 Q1
5 quarters
|
|
5614
Monte Rosa Therapeutics
GLUE
$961M
| $50.2K | ﹤0.01% |
13,418
+597
| +5% | +$3.04K |
2021 Q3
11 quarters
|
|
|
QIWI
5615
DELISTED
QIWI PLC
QIWI
| $49.9K | ﹤0.01% |
8,806
| – | – |
2014 Q1
41 quarters
|
|
5616
Principal Spectrum Preferred Securities Active ETF
PREF
$1.85B
| $49.9K | ﹤0.01% |
+2,736
| New | +$49.6K |
2024 Q2
0 quarters
|
|
5617
PUT
Fastly Inc
FSLY
$4.2B
| $49.4K | ﹤0.01% |
6,700
-11,300
| -63% | -$111K |
2024 Q1
1 quarter
|
|
5618
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$1.97B
| $49.3K | ﹤0.01% |
2,178
+1,167
| +115% | +$26.3K |
2023 Q4
2 quarters
|
|
|
GRIN
5619
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $49.2K | ﹤0.01% |
3,570
-90
| -2% | -$1.22K |
2018 Q3
23 quarters
|
|
5620
Northern Trust iBoxx 5-Year Target Duration TIPS ETF
TDTF
$1.03B
| $49.1K | ﹤0.01% |
2,099
-567
| -21% | -$13.2K |
2023 Q2
4 quarters
|
|
5621
First Trust New York Municipal High Income ETF
FMNY
$36.2M
| $49.1K | ﹤0.01% |
1,831
+1,411
| +336% | +$37.7K |
2023 Q3
3 quarters
|
|
5622
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$216M
| $49K | ﹤0.01% |
1,382
-657
| -32% | -$25.4K |
2022 Q3
7 quarters
|
|
5623
CALL
Fabrinet
FN
$16.2B
| $49K | ﹤0.01% |
+200
| New | +$42.4K |
2024 Q2
0 quarters
|
|
|
5624
PUT
Fabrinet
FN
$16.2B
| $49K | ﹤0.01% |
+200
| New | +$42.4K |
2024 Q2
0 quarters
|
|
|
IGMS
5625
DELISTED
IGM Biosciences
IGMS
| $48.6K | ﹤0.01% |
7,073
+1,237
| +21% | +$10.6K |
2019 Q4
18 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.